Q1 Earnings Roundup: Akamai Beats Estimates, Axon Sees Slight Dip, Cutera Takes a Hit, and Wynn Resorts Holds Steady
- May 09th, 2023
- 596 views
In the latest round of Q1 earnings reports, Akamai Technologies, Inc. (Nasdaq: AKAM) beat consensus estimates with an adjusted EPS of $1.40, compared to the expected $1.32. This news was well-received by investors, as AKAM's stock price increased by $3.62 per share (+4.59%) in after-hours trading, currently trading at $82.50.
On the other hand, Axon Enterprise, Inc. (Nasdaq: AXON) reported a non-GAAP EPS of $0.88 for Q1, which surpassed the consensus estimate of $0.53. However, AXON's stock price saw a slight decrease of $1.88 per share (-0.83%) in after-hours trading and is currently trading at $225.00.
Cutera, Inc. (Nasdaq: CUTR) reported a Q1 loss of $1.26 per share, which was significantly worse than the consensus loss of $0.39 per share. This news led to a significant drop in CUTR's stock price, decreasing by $2.58 per share (-12.77%) in after-hours trading, currently trading at $17.62.
Wynn Resorts, Limited (Nasdaq: WYNN) also reported a Q1 loss of $0.02 per share, slightly worse than the consensus loss of $0.01 per share. However, WYNN's stock price saw a small increase of $0.79 per share (+0.71%) in after-hours trading and is currently trading at $112.49.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
Countdown to Earnings: Nutanix, CrowdStrike, and Synopsys on Deck
August 23rd, 2026Investors Eye Semtech, Intuit, and nCino as Earnings Loom
August 22nd, 2026FTC Files Amicus Brief to Protect Competition in Biologic Drug Markets
August 21st, 2026




Member Login